Esophageal cancer T2an1m0 should be esophageal cancer T2N1M0 staging, which mainly describes that the patient’s cancer invades the intrinsic muscular layer and is accompanied by 1-2 regional lymph node metastasis, and no distant metastasis has been found for the time being. At present, TNM staging methods are commonly used to describe the progression of esophageal cancer and other malignant tumors from three aspects, among which T2N1M0 stage for esophageal cancer mainly describes that the cancer invades the intrinsic layer of the muscle and is accompanied by lymph node metastasis in 1~2 regions, and at the same time, distant metastasis has not been detected for the time being, and the patients with esophageal cancer T2N1M0 need to further specify the histological type and perfect other auxiliary examinations and targeted treatment. Treatment. According to the specific histological type of the patient, the pathological and clinical stages of the patient can be further determined, and the degree of differentiation of the patient’s tumor cells can be determined at the same time. It is recommended that patients diagnosed with esophageal cancer should consult the Department of Oncology of regular hospitals.